Oxford BioMedica to Participate in Credit Suisse’s Global Healthcare One-on-One Conference

2 March 2015

London, UK – 3 March 2015: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE:OXB), a leading gene and cell therapy company, announces that John Dawson, Chief Executive Officer, and Tim Watts, Chief Financial Officer, will participate in the Credit Suisse Global Healthcare One-on-One Conference on 3 March 2015, in London.

The conference is predominantly one-on-one meetings between investors and senior management teams from more than 50 global healthcare companies. The conference is open to companies by invitation only.

– Ends –